| CTRI Number |
CTRI/2025/09/094268 [Registered on: 04/09/2025] Trial Registered Prospectively |
| Last Modified On: |
04/09/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Compare Bupivacaine vs Bupivacaine and Dexmedetomidine given in joint for Postoperative pain in Arthroscopic Knee surgery patients |
|
Scientific Title of Study
|
Comparison of intra-articular Bupivacaine vs Bupivacaine and Dexmedetomidine for Postoperative Analgesia in Arthroscopic Knee surgery patients |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Inderjeet Singh |
| Designation |
PG Resident |
| Affiliation |
Adesh Institute of Medical Sciences and Research |
| Address |
Department of Anesthesiology and Intensive Care, Adesh Institute of Medical Sciences and Research,Bathinda,151001, India
Bathinda PUNJAB 151001 India |
| Phone |
8284882936 |
| Fax |
|
| Email |
ind2936@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Usha Devi |
| Designation |
Associate professor |
| Affiliation |
Adesh Institute of Medical Sciences and Research |
| Address |
Department of Anesthesiology and Intensive Care, Adesh Institute of Medical Sciences and Research,Bathinda,151001, India
Bathinda PUNJAB 151001 India |
| Phone |
9915461044 |
| Fax |
|
| Email |
sonaattri45@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Inderjeet Singh |
| Designation |
PG Resident |
| Affiliation |
Adesh Institute of Medical Sciences and Research |
| Address |
Department of Anesthesiology and Intensive Care, Adesh Institute of Medical Sciences and Research,Bathinda,151001, India
Bathinda PUNJAB 151001 India |
| Phone |
8284882936 |
| Fax |
|
| Email |
ind2936@gmail.com |
|
|
Source of Monetary or Material Support
|
| Adesh University, Bathinda, 151001,Punjab,India |
|
|
Primary Sponsor
|
| Name |
Adesh University |
| Address |
Adesh Institute of Medical Sciences and Research Bathinda,Punjab,151001 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Inderjeet Singh |
Adesh hospital |
OT Complex of Anesthesiology and Intensive care department Bathinda PUNJAB |
8284882936
ind2936@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| ETHICS COMMITTEE ADESH UNIVERSITY |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M00-M99||Diseases of the musculoskeletal system and connective tissue, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
BUPIVACAINE (0.5%) 1ML AND DEXMEDETOMIDINE (50MCG) 14ML intraoperative at end of surgery |
GIVEN INTRA ARTICULAR IN KNEE JOINTS |
| Intervention |
BUPIVACAINE(O.5%) 14 ml + 1ml NS intraoperative at end of surgery |
GIVEN INTRA ARTICULAR IN KNEE JOINTS |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
ASA (American Society of Anaesthesiologists) physical status I and II
Age:18-60 years
Patients scheduled for elective arthroscopic knee surgeries under spinal anesthesia
Duration of surgery between 90-150 minutes
|
|
| ExclusionCriteria |
| Details |
patients allergic to this drug, coagulation disorders , pregnant females , sepsis present , obesity
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| compare post op pain |
compare post op pain FOR 24 HOURS |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| haemodynamics changess |
post op FOR 24 HOURS |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2 |
|
Date of First Enrollment (India)
|
17/09/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - All of the individual participant data collected during the trial, after de-identiļ¬cation.
- What additional supporting information will be shared?
Response - Study Protocol Response - Statistical Analysis Plan Response - Informed Consent Form Response - Clinical Study Report
- Who will be able to view these files?
Response - Anyone
- For what types of analyses will this data be available?
Response - To achieve aims in the approved proposal.
- By what mechanism will data be made available?
Response - Proposals should be directed to [ind2936@gmail.com].
- For how long will this data be available start date provided 01-09-2025 and end date provided 31-12-2026?
Response - Immediately following publication. No end date.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - nil
|
|
Brief Summary
|
we are comparing effect on post op pain by bupivacaine vs bupivacaine and dexmedetomidine given intra articular in arthroscopic knee surgery patients in next 24 hours. |